5ちゃんねる ★スマホ版★ ■掲示板に戻る■ 全部 1- 最新50  

■ このスレッドは過去ログ倉庫に格納されています

【4565】そーせいG363【株価もIPも復活 俺が上昇トレンド復活宣言】 [無断転載禁止]©2ch.net

102 :山師さん@トレード中 (キュッキュ a1c6-gIMr [202.124.48.64]):2016/09/09(金) 20:31:00.10 ID:iQNbH8bL00909
※Heptares Event update

European CNS Summit 2016: September 12-14, 2016, London
・13th September, 10:00, Panel Discussion: "Achieving the Goal of Cost Effective, Non-Invasive Biomarkers": Alastair Brown, Head of Pharmacology, Heptares
・14th September, 15:45, "Opportunities & Challenges in the Biotech World": Alastair Brown, Head of Pharmacology, Heptares

※Wnt Meeting 2016 - EMBO Conference, Brno, Czech Republic: Sep 14-17, 2016
・Poster Presentation

Basel Life Science Week 2016: Current challenges in protein science: from fundamental research to drug development, September 20-21, 2016.
・20 September, 17:05 - 17:30, "Building a complete picture; kinetics, thermodynamics and the structural determination of stabilised GPCRs": Elena Segala (Heptares)

Unlocking the Potential of Synthetic Biology to Enhance Human Health: 27th - 29th September 2016
”Engineering G protein-coupled receptors to facilitate structure determination and structure-based drug design”
Chris Tate, MRC Laboratory of Molecular Biology,Cambridge, United Kingdom.
・Heptares has grown into a world-leading drug discovery biotech company that uses structure-based drug design to develop new therapeutics that are now entering the clinic.

16th Annual Biotech in Europe Forum: Basel, Switzerland: Sep 27-28, 2016
・27th September 14:00, ”Neuroscience I – Alzheimer’s Disease”: Panellists: Malcolm Weir, Co-Founder and Chief Executive Officer, Heptares
・Presenting (Business Development): Malcolm Weir, Co-Founder and Chief Executive Officer, Heptares

12th Swiss Course on Medicinal Chemistry: October 9-14th, 2016: Leysin, Switzerland.
・Target Family-directed Approaches: "Fragment-Based Lead Generation for GPCR modulators": Dr.Jonathan Mason, Drug Design and Computational Chemistry Expert at Heptares.

※11th Annual Peptide Therapeutics Symposium, La Jolla, CA, USA: Oct 27-28, 2016
・October 27, 16:00 - 16:30, Presenting: Ali Jazayeri, Hepatres Therapeutics.

World Preclinical Congress Europe: Mastering Medicinal Chemistry, Lisbon, Portugal: 14 - 15 November, 2016
14 November: MEASURING & PREDICTING DRUG EFFICACY
・8:25, Chairperson’s Opening Remarks: Jonathan Mason, Heptares.
・9:30, ”High End GPCR Drug Design: Using New GPCR X-Ray Structures to Predict Potency, Selectivity & Kinetics”: Jonathan Mason, Ph.D., Senior Research Fellow, Head CADD, Drug Discovery, Heptares.

・・・

HeptaresのR&Dの進展と拡大も楽しみですね。笑。

165 KB
■ このスレッドは過去ログ倉庫に格納されています

★スマホ版★ 掲示板に戻る 全部 前100 次100 最新50

read.cgi ver 05.04.00 2017/10/04 Walang Kapalit ★
FOX ★ DSO(Dynamic Shared Object)